Concepedia

Donald Bennett

DB

17

Publications

1.4K

Citations

16

H-Index

1981

Active since

Affiliations

Pfizer (United States)(Current)

Biogen (United States)

Newcastle University

Johns Hopkins University

University of Maryland, Baltimore

Donald Bennett is an author at Pfizer (United States) specializing in medicine, immunology, and autoimmune disease.

Top concepts

Publications per year

1981–2023

17

Publications

17

BG9719 (CVT-124), an A <sub>1</sub> Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy

Stephen S. Gottlieb, D. Craig Brater, Ignatius Thomas et al. · Circulation · 2002 · 370 citations

Neutralizing antibodies and efficacy of interferon β-1a

Ludwig Kappos, Michel Clanet, Magnhild Sandberg‐Wollheim et al. · Neurology · 2005 · 201 citations

GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates

Danna M. Breen, Hanna Kim, Donald Bennett et al. · Cell Metabolism · 2020 · 168 citations

, , +10

Effects of BG9719 (CVT-124), an A1-Adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

Stephen S. Gottlieb, Sandra Skettino, Andrew A. Wolff et al. · Journal of the American College of Cardiology · 2000 · 147 citations

, , +8

Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis

C. Huard, Stefano V. Gullà, Donald Bennett et al. · British Journal of Dermatology · 2016 · 144 citations

Rows per page

1–5 of 17